Meno a priezvisko:
|
Mgr. Agáta Očenášová
|
Typ dokumentu:
|
Vedecko/umelecko-pedagogická charakteristika osoby
|
Názov vysokej školy:
|
Univerzita Komenského v Bratislave
|
Sídlo vysokej školy:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Zamestnanie-pracovné zaradenie | III.b - Inštitúcia | III.c - Časové vymedzenie |
---|---|---|
Laboratórny diagnostik | Medirex a.s., Bratislava | 2020-2022 |
IV.a - Popis aktivity, názov kurzu (ak išlo o kurz), iné | IV.b - Názov inštitúcie | IV.c - Rok |
---|---|---|
TOEFL iBT Test | TOEFL iBT | 2017 |
V.1.a - Názov profilového predmetu | V.1.b - Študijný program | V.1.c - Stupeň | V.1.d - Študijný odbor |
---|---|---|---|
Imunológia | všeobecné lekárstvo | II. stupeň | všeobecné lekárstvo |
Ocenasova A, Shawkatova I, Javor J, et al. MMP2 rs243866 and rs2285053 Polymorphisms and Alzheimer's Disease Risk in Slovak Caucasian Population. Life (Basel). 2023;13(4):882. (IF = 3,2; Q2)
Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Reznakova V, Kralova M, Hromadka T, Shawkatova I. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients. Mediators of Inflammation. 2021;2021:5573642. (IF = 4,53; Q2)
Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Kiralyova I, Sutovsky S, Petrovic R, Shawkatova I. TREM2 coding variants in Slovak Alzheimer's disease patients. Journal of integrative neuroscience. 2022;21(4):105. (IF = 1,8; Q3)
Durmanova V, Tedla M, Rada D, Bandzuchova H, Kuba D, Suchankova M, Ocenasova A, Bucova M. Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients. Diseases (Basel, Switzerland). 2024;12(2):34. (IF = 3,7; Q2)
Ocenasova A, Shawkatova I, Javor J, et al. MMP2 rs243866 and rs2285053 Polymorphisms and Alzheimer's Disease Risk in Slovak Caucasian Population. Life (Basel). 2023;13(4):882. (IF = 3,2; Q2)
Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Reznakova V, Kralova M, Hromadka T, Shawkatova I. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients. Mediators of Inflammation. 2021;2021:5573642. (IF = 4,53; Q2)
Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B, Kiralyova I, Sutovsky S, Petrovic R, Shawkatova I. TREM2 coding variants in Slovak Alzheimer's disease patients. Journal of integrative neuroscience. 2022;21(4):105. (IF = 1,8; Q3)
Durmanova V, Tedla M, Rada D, Bandzuchova H, Kuba D, Suchankova M, Ocenasova A, Bucova M. Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients. Diseases (Basel, Switzerland). 2024;12(2):34. (IF = 3,7; Q2)
článok: Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, et al. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients. Mediators of Inflammation. 2021;2021:5573642.
citovaný v článku: Pintér P, Alpár A. The Role of Extracellular Matrix in Human Neurodegenerative Diseases. International journal of molecular sciences 2022;23(19):11085. (Q1)
článok: Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, et al. Impact of MMP2 rs243865 and MMP3 rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients. Mediators of Inflammation. 2021;2021:5573642.
citovaný v článku: Xu Y, Yan H, Zhang X, et al. Roles of Altered Macrophages and Cytokines: Implications for Pathological Mechanisms of Postmenopausal Osteoporosis, Rheumatoid Arthritis, and Alzheimer's Disease. Frontiers in endocrinology. 2022;13:876269. (Q1)
článok: Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, et al. TREM2 coding variants in Slovak Alzheimer's disease patients. Journal of integrative neuroscience. 2022;21(4):105.
citovaný v článku: Shang X, Maimaiti N, Fan J, et al. Triggering Receptor Expressed on Myeloid Cells 2 Mediates the Involvement of M2-Type Macrophages in Pulmonary Tuberculosis Infection. Journal of inflammation research. 2024;17:1919-1928. (Q2)
súčasť riešiteľského kolektívu - VEGA 1/0738/20 - Biomarkery neurozápalu u pacientov s Alzheimerovou chorobou
zodpovedná riešiteľka grantu - UK/245/2022 - Genetické polymorfizmy v promótorových oblastiach MMP2 a riziko rozvoja Alzheimerovej choroby v slovenskej populácii
zodpovedná riešiteľka grantu - UK/301/2023 - Genetické polymorfizmy v regulačných oblastiach génu HLAG a riziko rozvoja Alzheimerovej choroby v slovenskej populácii